Obesity and cancer risk: Emerging biological mechanisms and perspectives

KI Avgerinos, N Spyrou, CS Mantzoros, M Dalamaga - Metabolism, 2019 - Elsevier
Continuously rising trends in obesity-related malignancies render this disease spectrum a
public health priority. Worldwide, the burden of cancer attributable to obesity, expressed as …

[HTML][HTML] Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation

R Divella, R De Luca, I Abbate, E Naglieri… - Journal of …, 2016 - ncbi.nlm.nih.gov
Adipose tissue in addition to its ability to keep lipids is now recognized as a real organ with
both metabolic and endocrine functions. Recent studies demonstrated that in obese animals …

Obesity and breast cancer: role of leptin

F Sánchez-Jiménez, A Pérez-Pérez… - Frontiers in …, 2019 - frontiersin.org
Obesity-related breast cancer is an important threat that affects especially post-menopausal
women. The link between obesity and breast cancer seems to be relying on the …

The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape

D Zipinotti dos Santos, JC de Souza… - Cell Communication and …, 2023 - Springer
Background Breast cancer (BC) is the second most frequent type of cancer in the world and
most common among women, configuring a major challenge to global health. BC is a …

Obesity-associated breast cancer: analysis of risk factors

A Engin - Obesity and lipotoxicity, 2017 - Springer
Several studies show that a significantly stronger association is obvious between increased
body mass index (BMI) and higher breast cancer incidence. Furthermore, obese women are …

Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2

J Incio, JA Ligibel, DT McManus, P Suboj… - Science translational …, 2018 - science.org
Anti–vascular endothelial growth factor (VEGF) therapy has failed to improve survival in
patients with breast cancer (BC). Potential mechanisms of resistance to anti-VEGF therapy …

Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming

DV Pham, PH Park - Journal of Experimental & Clinical Cancer Research, 2022 - Springer
Background Adiponectin, the most abundant adipokine derived from adipose tissue, exhibits
a potent suppressive effect on the growth of breast cancer cells; however, the underlying …

Metabolic syndrome and breast cancer: prevalence, treatment response, and prognosis

S Dong, Z Wang, K Shen, X Chen - Frontiers in oncology, 2021 - frontiersin.org
Metabolic syndrome is a type of multifactorial metabolic disease with the presence of at least
three factors: obesity, diabetes mellitus, low high-density lipoprotein, hypertriglyceridemia …

Macrophage polarization: anti‐cancer strategies to target tumor‐associated macrophage in breast cancer

M Tariq, J Zhang, G Liang, L Ding… - Journal of cellular …, 2017 - Wiley Online Library
Tumor‐associated macrophages (TAMs) are the most abundant inflammatory cells and
orchestrate different stages of breast cancer development. TAMs participate in the tumor …

Leptin: A heavyweight player in obesity-related cancers

A Caruso, L Gelsomino, S Panza, FM Accattatis… - Biomolecules, 2023 - mdpi.com
Obesity, defined as the abnormal or excessive expansion of white adipose tissue, has
reached pandemic proportions and is recognized as an important health concern since it is …